Aerie Pharma (AERI) Misses Q3 EPS by 10c

Aerie Pharma (NASDAQ: AERI) reported Q3 EPS of ($0.72), $0.10 worse than the analyst estimate of ($0.62). Revenue for the quarter came in at $0 versus the consensus estimate of $28.99 million.

For earnings history and earnings-related data on Aerie Pharma (AERI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15